Varta
← Back to stories

From The Hindu

Center-Left Owned by Kasturi & Sons Ltd.

Revised MRPs of 1,364 anti-cancer formulations come into effect; consumers to save ₹3,540 crore/year

Revised MRPs of 1,364 anti-cancer formulations come into effect; consumers to save ₹3,540 crore/year

What's behind this

Revised MRPs of 1,364 anti‑cancer formulations took effect on Monday, projected to save consumers about Rs 3,540.38 crore per year. The Department of Pharmaceuticals reported that 679 brands saw price cuts exceeding 50%, with the biggest reduction of 96.45%. The National Pharmaceutical Pricing Authority is the agency overseeing the pricing.

AI-generated overview from 3 outlets. It summarises their reporting and adds no reporting of its own.

What each side is saying

One outlet's own words from each side of the spectrum. Quoted, not summarised.

  • left · 2 outlets

    According to the Ministry, 85 pharmaceutical companies have reported revised MRPs for 1,364 anti-cancer formulations across 121 drugs as of November 8, 2026

    — The Hindu

  • center · 3 outlets

    New Delhi: Revised Maximum Retail Prices (MRPs) of 1,364 anti-cancer formulations have come into effect from Monday, a move projected to save consumers an estimated Rs 3,540.38 crore annually, according to an official release. The National Pharmaceutical Pricing Authority (NPPA), functioning under…

    — Orissa Post

RSS excerpt

According to the Ministry, 85 pharmaceutical companies have reported revised MRPs for 1,364 anti-cancer formulations across 121 drugs as of November 8, 2026

Coverage arrived over 0 hours — first from The New Indian Express, latest from DT Next.

High Corroboration Cross-Spectrum Consensus 5 news outlets reporting

Fact-Check & Bias Analysis

Confirmed by multiple independent newsrooms across the political spectrum.

Coverage Bias Distribution

Based on 5 reporting publishers
Left / Center-Left 2 (40%)
Center 3 (60%)
Center-Right / Right 0 (0%)
Little coverage from right-leaning outlets.

Compare all reporting outlets (5)

  1. The New Indian Express Center Express Publications (Madurai) Ltd.

    Prices of 1,364 anti-cancer drug formulations revised, consumers set to save Rs 3,540 crore annually

    NEW DELHI: Revised Maximum Retail Prices (MRPs) of 1,364 anti-cancer formulations have come into effect from Monday, a move projected to save consumers an estimated Rs 3,540.38 crore annually, according to an official release. The National Pharmaceutical Pricing Authority (NPPA), functioning under…

  2. Moments later
  3. Orissa Post Center Eastern Media Ltd (Sambad Group)

    Revised MRPs of 1,364 anti-cancer formulations come into effect; consumers to save Rs 3,540 cr/year

    New Delhi: Revised Maximum Retail Prices (MRPs) of 1,364 anti-cancer formulations have come into effect from Monday, a move projected to save consumers an estimated Rs 3,540.38 crore annually, according to an official release. The National Pharmaceutical Pricing Authority (NPPA), functioning under…

  4. 3 minutes later
  5. 5 minutes later
  6. The Hindu Center-Left Kasturi & Sons Ltd. Current article

    Revised MRPs of 1,364 anti-cancer formulations come into effect; consumers to save ₹3,540 crore/year

    According to the Ministry, 85 pharmaceutical companies have reported revised MRPs for 1,364 anti-cancer formulations across 121 drugs as of November 8, 2026

  7. 25 minutes later
  8. DT Next Center Daily Thanthi Group

    Revised MRPs of 1,364 anti-cancer formulations come into effect; patients to save Rs 3,540 cr/year

    NEW DELHI: Revised Maximum Retail Prices (MRPs) of 1,364 anti-cancer formulations have come into effect from Monday, a move projected to save consumers an estimated Rs 3,540.38 crore annually, according to an official release. The National Pharmaceutical Pricing Authority (NPPA), functioning under…

Read more news

See all latest stories →